China Resources Pharmaceutical Group (3320.HK) Financial Analysis & Valuation | Quarter Chart
China Resources Pharmaceutical Group (3320.HK)
3320.HKPrice: $0.61
Fair Value: 🔒
🔒score
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manu... more
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research... more
Description
Shares
| Market Cap | $3.80B | Exchange | HKSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | HK | CEO | Xiaosong Bai |
| IPO Date | 2016-10-28 | CAGR | 0.08% |
| Employees | 72,700 | Website | www.crpharm.com |
| Div. Yield | 3.07% | Payout Ratio | 0.17% |
| Buy Back Yield | 14.16% | Total Yield | 17.23% |
3320.HK chart loading...
Fundamentals
Technicals
| Enterprise Value | $102.18B | P/E Ratio | 6.41 |
| Forward P/E | 5.28 | PEG Ratio | 0.04 |
| P/S Ratio | 0.1 | P/B Ratio | 0.47 |
| P/CF Ratio | 1.41 | P/FCF Ratio | 1.58 |
| EPS | $0.09 | EPS Growth 1Y | -3.76% |
| EPS Growth 3Y | 11.31% | EPS Growth 5Y | -1.54% |
| Revenue Growth 1Y | 8.98% | Gross Margin | 0.17% |
| Operating Margin | 0.05% | Profit Margin | 0.02% |
| ROE | 0.08% | ROA | 0.01% |
| ROCE | 0.09% | Current Ratio | 1.42 |
| Quick Ratio | 1.11 | Cash Ratio | 0.19 |
| Debt/Equity | 1.83 | Interest Coverage | 6.27 |
| Altman Z Score | 2.43 | Piotroski Score | 7 |
View China Resources Pharmaceutical Group financial charts →